Delivery Order SPE2DB20D3104-SPE2DB23FV8Z8
- Not listed
- This federal contract award, issued by the Defense Logistics Agency (DLA), is for the delivery of 4,560,315,275 units of Naloxone HCL 4 mg Nasal Spray. The $2,556.39 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 21, 2023 and is not designated as a set-aside requirement. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,557,932,236 units of Naloxone HCL 4 mg Nasal Spray. The $3,078.00 firm fixed-price delivery order has a completion date of July 29, 2022 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,081.74 firm-fixed-price delivery order is for the supply of 4,559,542 units of 4 mg naloxone hydrochloride nasal spray. The contract has an ultimate completion date of January 10, 2023 and is not associated with any set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,615.87 delivery order is for the supply of 4,566,149,706 units of Naloxone HCL 4 mg Nasal Spray, a critical medication used for the emergency treatment of opioid overdose. The contract has an ultimate completion date of October 21, 2024 and is a firm fixed-price delivery order, with no set-aside designation...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $13,298.28, is for the delivery of 4,563,004,099 units of Naloxone HCL 4 mg Nasal Spray by December 6, 2023. This contract is a Firm Fixed Price Delivery Order and was not designated as a set-aside. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has been...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,725.43 firm fixed-price delivery order is for the supply of 4,560,996,700 units of Naloxone HCl 4 mg Nasal Spray. The contract has an ultimate completion date of May 22, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,524.80 firm fixed price delivery order is for the supply of 4 mg Naloxone HCl nasal spray, a critical medication used to treat opioid overdose. The contract has an ultimate completion date of January 29, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of 4,559,406,389 units of Naloxone HCl 4 mg Nasal Spray to the Defense Logistics Agency (DLA). The award, valued at $3,854.16, was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a period of performance through December 19, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,429.84 firm fixed-price delivery order is for the supply of 4,558,579,540 units of Naloxone HCl 4 mg nasal spray. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical products to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,850.00 firm fixed price delivery order is for the supply of 4,557,029,077 units of Naloxone HCl 4 mg Nasal Spray, with a completion date of April 28, 2022. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB23FV8Z8Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,780.87 Firm Fixed Price Delivery Order is for the supply of 4,562,158,402 units of Naloxone HCl 4 mg Nasal Spray. The award has an ultimate completion date of September 14, 2023 and was made on September 13, 2023. There was no set-aside designation for this contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These contracting mechanisms enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.8k | 9/13/23 |